ATORvastatin in Pulmonary TUBerculosis
Conditions
Pulmonary Tuberculosis · Tuberculosis · Koch's Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Tuberculosis Reference Laboratory, Zaria, Kaduna State, Nigeria
Eunice Jiya (Sub-investigator)Federal Teaching Hospital, Katsina, Katsina State, Nigeria
Contact: Study coordinator (Taofeek Oloyede)Federal Medical Center, Keffi, Nasarawa State, Nigeria
Contact: Study coordinator (Modupe Ogunsina, Dr)Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria
Contact: Study coordinator (Olufemi Adewole, MD)Contact: Principal Investigator (Olanisun Olufemi Adewole, MD)Bolanle A Omotoso, MD (Sub-investigator)Yemi Awopeju (Sub-investigator)Greg E Erhabor (Sub-investigator)Tewogbade Adedeji, MD (Sub-investigator)Temitayo Adewole, MD (Sub-investigator)Olugbenga Ayoola, MD (Sub-investigator)Bowen University Teaching Hospital, Iwo, Osun State, Nigeria
Abiona Odeyemi (Sub-investigator)University College Hospital, Ibadan, Oyo State, Nigeria
Usman Danfodio University, Sokoto, Sokoto State, Nigeria
Aminu Abbas, MD (Sub-investigator)University of Abuja Teaching Hospital, Gwagwalada, Nigeria
Contact: Study coordinator (Alex Akor, MD)
Study leads
Olanisun O Adewole, MD
Principal Investigator
Obafemi Awolowo University /Teaching Hospital, Ile- Ife, Osun State, Nigeria
Olanisun O Adewole, MD
Study Chair
Obafemi Awolowo University/ Teaching Hospital, Ile- Ife, Osun State, Nigeria
Bolanle A Omotoso, MD
Study Director
Obafemi Awolowo University/ Teaching Hospital, Ile- Ife, Osun State, Nigeria